Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Parkin

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
Equine Veterinary Journal|February 16, 2016
Prevalence, risk factors and genetic parameters of cresty neck in Pura Raza Español horsesM J Sánchez, P J Azor, A Molina, et al.
The Journal of Biological Chemistry|July 31, 2013
The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell linesDavid A Hicks, Natalia Z Makova, Mallory Gough, et al.
Journal of Clinical Microbiology|January 25, 2013
Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimensGavin A Cloherty, James Rhoads, Thomas P Young, et al.
Equine Veterinary Journal|May 21, 2008
The use of race winnings, ratings and a performance index to assess the effect of thermocautery of the soft palate for treatment of horses with suspected intermittent dorsal displacement. A case-control study in 110 racing ThoroughbredsR J M Reardon, B S L Fraser, J Heller, et al.
Biochemistry|April 10, 2002
Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alphaEdward T Parkin, Alison Trew, Gary Christie, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
The Journal of Infectious Diseases|August 7, 1999
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapyN T Parkin, Y S Lie, N Hellmann, et al.
Peptides|March 19, 2002
Inactivation of a tachykinin-related peptide: identification of four neuropeptide-degrading enzymes in neuronal membranes of insects from four different ordersR Elwyn Isaac, Edward T Parkin, Jeffrey N Keen, et al.
Journal of Clinical Microbiology|February 4, 2011
Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutationsThomas P Young, Gavin Cloherty, Signe Fransen, et al.
Organic Letters|February 25, 2005
A Cyclopropabenzenylidenethenone (propadienone) via a new route to alkylidenecycloproparenesBrian Halton, Gareth M Dixon, Carissa S Jones, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
Equine Veterinary Journal|February 16, 2016
Prevalence, risk factors and genetic parameters of cresty neck in Pura Raza Español horsesM J Sánchez, P J Azor, A Molina, et al.
The Journal of Biological Chemistry|July 31, 2013
The amyloid precursor protein represses expression of acetylcholinesterase in neuronal cell linesDavid A Hicks, Natalia Z Makova, Mallory Gough, et al.
Journal of Clinical Microbiology|January 25, 2013
Sequence conservation of the region targeted by the Abbott RealTime HBV viral load assay in clinical specimensGavin A Cloherty, James Rhoads, Thomas P Young, et al.
Equine Veterinary Journal|May 21, 2008
The use of race winnings, ratings and a performance index to assess the effect of thermocautery of the soft palate for treatment of horses with suspected intermittent dorsal displacement. A case-control study in 110 racing ThoroughbredsR J M Reardon, B S L Fraser, J Heller, et al.
Biochemistry|April 10, 2002
Structure-activity relationship of hydroxamate-based inhibitors on the secretases that cleave the amyloid precursor protein, angiotensin converting enzyme, CD23, and pro-tumor necrosis factor-alphaEdward T Parkin, Alison Trew, Gary Christie, et al.
Antimicrobial Agents and Chemotherapy|September 1, 2010
Prevalence, mutation patterns, and effects on protease inhibitor susceptibility of the L76V mutation in HIV-1 proteaseThomas P Young, Neil T Parkin, Eric Stawiski, et al.
The Journal of Infectious Diseases|August 7, 1999
Phenotypic changes in drug susceptibility associated with failure of human immunodeficiency virus type 1 (HIV-1) triple combination therapyN T Parkin, Y S Lie, N Hellmann, et al.
Peptides|March 19, 2002
Inactivation of a tachykinin-related peptide: identification of four neuropeptide-degrading enzymes in neuronal membranes of insects from four different ordersR Elwyn Isaac, Edward T Parkin, Jeffrey N Keen, et al.
Journal of Clinical Microbiology|February 4, 2011
Performance of the Abbott RealTime HIV-1 viral load assay is not impacted by integrase inhibitor resistance-associated mutationsThomas P Young, Gavin Cloherty, Signe Fransen, et al.
Organic Letters|February 25, 2005
A Cyclopropabenzenylidenethenone (propadienone) via a new route to alkylidenecycloproparenesBrian Halton, Gareth M Dixon, Carissa S Jones, et al.
Pageof 13